Biotech Companies & Organizations

For more information, please contact the appropriate organizations listed below. Links to other web sites do not constitute an endorsement or referral. This information is to be used for educational and informational purposes only. Medical information on the Chicago Center for Jewish Genetic Disorders’ Website, if any, does not represent advice regarding medical diagnosis or treatment, referrals to health care professionals, endorsements of health care products or any other recommendations. For medical information, please consult your doctor.



Celera Genomics
The company that raced the NIH’s human genome project to map the human genome.

Cell Genesys: Gene Therapy

*Cold Springs Harbor Laboratory
CSHL is a research and educational institution. The Laboratory has research programs focusing on cancer, neurobiology, genomics, and bioinformatics, and a broad educational mission. Find the Dolan DNA Learning Center here –a science museum and educational facility promoting DNA literacy with online articles.


The Cooperative Human Linkage Center

CuraGen Corporation

Gene Logic


A French site with an English version. Works on Gene Therapies and rare diseases.

The Genome Database
Hosted by the Hospital for Sick Children, Toronto, Canada

Genome Therapeutics Corporation


The Institute for Genomic Research: one of the six research institutes participating in the project to map the human genome. Non-profit affiliate of Human Genome Sciences. Controls over 150,000 ESTs.

National Center for Genome Resources

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading research-based pharmaceutical and biotechnology companies. Site contains policy issues, drugs being developed, a section on genomics including very useful bioethics information.

*The Wellcome Trust Sanger Institute

Lexicon Genetics, Inc.

Myriad Genetics
Company associated with the patent of BRCA 1 and BRCA 2.

Research Genetics, Inc.

Sequenom, Inc.

Vysis, Inc.

This page last updated on January 10, 2003.